Werfen to Acquire Immucor, Inc., Expanding its Presence in Specialized Diagnostics
Werfen enters into an agreement to acquire Immucor, Inc., a privately held, US-based corporation, with a solid global presence in transfusion and transplant in vitro diagnostics The transaction is expected to close during the first half of 2023 Werfen announced today that it has agreed to acquire Immucor, Inc., from TPG. Immucor is a privately […]
